Tech Company Financing Transactions
Montara Therapeutics Funding Round
On 6/2/2026, Montara Therapeutics raised $1 million in financing from The Michael J. Fox Foundation for Parkinson's Research.
Transaction Overview
Company Name
Announced On
6/2/2026
Transaction Type
Debt
Amount
$1,000,000
Round
Undisclosed
Investors
The Michael J. Fox Foundation for Parkinson's Research (Jessica Garcia)
Proceeds Purpose
The funding will be used to develop their BrainOnly� platform to activate autophagy in the brain, promote clearance of the toxic a-synuclein protein implicated in Parkinson's disease, while aiming to mitigate adverse effects throughout the body.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Montara, we're developing safer, more efficacious therapies to improve the lives of patients with neurological diseases. Our mission is to develop innovative therapies for diseases of the brain by leveraging our proprietary platform to enhance drug safety and efficacy and enable the drugging of targets previously considered undruggable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Hertz
Vice President
Randall Chin
Vice President
Zachary Hill
Vice President
Rishi Rakhit
VP - Operations
Max Lebovitz
Browse more venture capital transactions:
Prev: 6/2/2026: Archestra venture capital transaction
Next: 6/2/2026: Ilant Health venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs